First gene therapy — ‘a true living drug’ — on the cusp of FDA approval

Washington Post

11 July 2017 - When doctors saw the report on Bill Ludwig’s bone-marrow biopsy, they thought it was a mistake and ordered the test repeated. 

But the results came back the same: His lethal leukaemia had been wiped out by an experimental treatment never before used in humans.

“We were hoping for a little improvement,” remembered the 72-year-old retired New Jersey corrections officer, who had battled the disease for a decade. He and his oncologist both broke down when she delivered the good news in 2010. “Nobody was hoping for zero cancer.”

Read Washington Post article


Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Cellular therapy